NIIMBL Funds Eight New Biopharma Technology and Workforce Projects

NIIMBL has selected eight new member-led technology and workforce development projects totaling $9.7 million in funding and co-investment through its Project Call 9.1, announced in a press release. The initiative involves 39 participating organizations focused on improving domestic biopharmaceutical manufacturing and workforce capabilities.

The technology projects address areas such as process analytics, AI and machine learning for process optimization, and new protein expression platforms for advanced therapeutics. Participants include universities and industry partners such as Michigan Technological University, University of Delaware, Massachusetts Institute of Technology, and several major biopharma companies.

Three workforce projects aim to expand interest in biopharmaceutical manufacturing careers and develop an AI-ready workforce. These include initiatives led by the University City Science Center, the National Center for Therapeutics Manufacturing at Texas A&M University, and The Wistar Institute.

Since its launch in 2017, NIIMBL has supported 230 technical and workforce projects totaling more than $216 million. The institute operates as part of Manufacturing USA, funded through a cooperative agreement with the National Institute of Standards and Technology.